Back to Results
First PageMeta Content
Diabetes / Eli Lilly and Company / Glucagon / Hepatology / Blood sugar / Galician language / Endocrine system / Biology / Anatomy


Development of Inhalable SustainedSustained-Release Formulation of Glucagon T2066 â—‹Satomi Onoue 1, Kazuki Kuriyama 1, Atsushi Uchida 1, Takahiro Mizumoto 2, George Nemoto 3, and Shizuo Yamada 1 1
Add to Reading List

Document Date: 2011-10-19 12:59:47


Open Document

File Size: 756,03 KB

Share Result on Facebook

City

PLGA / /

Company

American Peptide Company / Japan ILS Inc. / Nanosphere / /

Country

Japan / /

Currency

IDR / /

Facility

U.S.A. UNIVERSITY OF SHIZUOKA / University of Shizuoka / AO JET MILL / /

IndustryTerm

polymer solution / oil / /

MedicalCondition

metabolic disorders / /

Organization

School of Pharmaceutical Pharmaceutical Sciences / Department of Pharmacokinetics and Pharmacodynamics / University of Shizuoka / U.S.A. UNIVERSITY OF SHIZUOKA / /

Person

George Nemoto / Atsushi Uchida / Takahiro Mizumoto / Kazuki Kuriyama / Satomi Onoue / Evelyn Ave. Sunnyvale / /

Product

LG PC12 Radio / Glucagon / /

ProvinceOrState

California / /

Technology

Pharmacokinetics / Pharmacodynamics / /

SocialTag